Citation Impact
Citing Papers
The use of polymeric platinum(IV) prodrugs to deliver multinuclear platinum(II) drugs with reduced systemic toxicity and enhanced antitumor efficacy
2012
Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex
2000
Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma
2004
Nanocarriers for delivery of platinum anticancer drugs
2013
Cisplatin: The first metal based anticancer drug
2019 Standout
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
New Developments and Approaches in the Platinum Arena
2000
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
Works of Robinson Am being referenced
A phase I study of a novel, trinuclear, platinum analogue, BBR3464, in patients with advanced solid tumors
1999